Sunakiment clinical trials
Also written AZD8630.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How each study uses sunakiment is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- AZD8630
- 4
Studies by the year they started
5 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses sunakiment is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of ExacerbationsCompletedPhase 2AstraZenecaNCT06529419Written as AZD8630
- A Study of Inhaled AZD8630 in Adolescents With AsthmaCompletedPhase 1AstraZenecaNCT07065331Written as AZD8630
- A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With AsthmaCompletedPhase 1AstraZenecaNCT06795906Written as AZD8630
- A Study to Investigate the Relative Bioavailability of AZD8630 Following a Device and Formulation Transition in Healthy Participants.CompletedPhase 1AstraZenecaNCT06531811Written as AZD8630 (test formulation) via test inhaler
- A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonistsCompletedPhase 1AstraZenecaNCT05110976Written as AZD8630
Codes
What other systems call sunakiment · ClinicalTrials.gg INT016634
- UNII (FDA) G5J5ELJ22VSUNAKIMENTOne source FDA
- NCI Thesaurus C224792SunakimentOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | G5J5ELJ22V | SUNAKIMENT | One source FDA |
| NCI Thesaurus | C224792 | Sunakiment | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.